摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one | 56198-34-6

中文名称
——
中文别名
——
英文名称
(3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one
英文别名
cis-Tetrahydro-1,3-bis(phenylmethyl)-1H-thieno<3,4-d>imidazol-2(3H)-one;(3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno[3,4-d]imidazol-2(3H)-one;N,N'-dibenzyl-cis-3,4-ureylenetetrahydrothiophene;1,3-dibenzyl-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one;1,3-Dibenzyl-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-on;(3aα,4α,6aα)-tetrahydro-1,3-dibenzyl-1H-thieno[3,4-d]imidazol-2(3H)-one;(3aR,6aS)-1,3-dibenzyl-3a,4,6,6a-tetrahydrothieno[3,4-d]imidazol-2-one
(3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one化学式
CAS
56198-34-6
化学式
C19H20N2OS
mdl
——
分子量
324.447
InChiKey
XOBCWQNPTJKLRJ-HDICACEKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    530.6±50.0 °C(Predicted)
  • 密度:
    1.259±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    48.8
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:015fdecc371c133b9e50b82151442d46
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of (+)-biotin: efficient resolution of key intermediates
    作者:Ron Bihovsky、Veeraiah Bodepudi
    DOI:10.1016/s0040-4020(01)90062-6
    日期:1990.1
    Enantiomerically pure 4-chlorothieno[3,4-]imidazol-2-one (+)-2 and thieno[3,4-]imidazol-2,4-dione (+)-5, key intermediates in independent routes to (+)-biotin (6), have been prepared by resolution via the corresponding diastereomeric ethers (3d-g and 3'd-g). Efficient procedures to recycle the undesired diastereomers and recover the chiral auxiliary have been developed.
    对映体纯的4-噻吩并[3,4- ]咪唑-2-酮(+)-2和噻吩并[3,4- ]咪唑-2,4-二酮(+)-5,它们是通往(+ -生物素(6),已经通过相应的非对映异构醚(3d-g和3'dg)拆分而制备。已经开发出有效的方法来回收不需要的非对映异构体并回收手性助剂。
  • THE REACTION OF 3,4-DIBROMOSULFOLANE WITH AMINES. A NEW METHOD FOR THE PREPARATION OF BIOTIN PRECURSOR
    作者:Hiroshi Kotake、Katsuhiko Inomata、Yasue Murata、Hideki Kinoshita、Masahiro Katsuragawa
    DOI:10.1246/cl.1976.1073
    日期:1976.10.5
    4-amino-2-sulfolene derivatives. Also, it was established that N,N′-dibenzyl-cis-ureylenetetrahydrothiophene as a precursor of biotin was derived from cis-3,4-bis(benzylamino)sulfolane prepared by the above reaction.
    发现3,4-二溴环丁砜与胺反应得到相应的3,4-二环丁砜或4-基-2-环丁砜生物。此外,已确定作为生物素前体的 N,N'-二苄基-顺式四氢噻吩源自通过上述反应制备的顺式-3,4-双(苄基基)环丁砜
  • STEREOSELECTIVE SYNTHESIS OF BIOTIN PRECURSOR
    作者:Hideki Kinoshita、Masato Futagami、Katsuhiko Inomata、Hiroshi Kotake
    DOI:10.1246/cl.1983.1275
    日期:1983.8.5
    Stereoselective synthesis of N,N′-dibenzyl-cis-ureylenetetrahydrothiophene as a precursor of biotin starting from the imidoyl chloride derivative readily prepared from the reaction of 3-sulfolene with sulfuryl chloride in acetonitrile was described.
    该研究描述了以 3-亚砜与硫酰氯乙腈中反应容易制备的亚胺生物为起点,立体选择性合成作为生物素前体的 N,N′-二苄基-顺式-四氢噻吩
  • Preparation of (3a.alpha.,6a.alpha.)-1,3-dibenzylhexahydro-1H-thieno[3,4-d]imidazol-2(3H)-one: a key biotin intermediate
    作者:Hans Aaron Bates、Lloyd Smilowitz、James Lin
    DOI:10.1021/jo00206a041
    日期:1985.3
  • Synthesis of a biotin-like phosphonate model compound for (+)-hydantocidin
    作者:Werner Föry、Hans Tobler
    DOI:10.1002/(sici)1096-9063(199906)55:6<668::aid-ps6>3.0.co;2-b
    日期:1999.6
查看更多

同类化合物

生物素-C5-叠氮 樟磺咪芬 四氢-4-(5-羟戊基)-(3AS,4S,6AR)-1H-噻吩并[3,4-D]咪唑-2(3H)-酮 咪噻吩 利地霉素 5-硫杂-1,2A-二氮杂环戊并[Cd]并环戊二烯 1,3-二苄基-4-羟基-4-(3-甲氧基丙基)四氢-1H-噻吩并[3,4-d]咪唑-2(3H)-酮 1,3-二苄基-2-氧代十氢噻吩并[1',2':1,2]噻吩并[3,4-d]咪唑-5-鎓溴化物 (3aS-顺式)-1,3-二苄基四氢-4-(3-甲氧基丙亚基)-1H-噻吩并[3,4-d]咪唑-2(3H)-酮 (3AS,4S,6AR)-1,3-二苄基-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-甲醛 3,4-(N-Monobenzyl-2'-oxoimidazolido)-2-(4-hydroxybutyl)-thiophan (1R,3R)-3-Cyclopentylidenemethyl-2,2-dimethyl-cyclopropanecarboxylic acid 2,5-dioxo-3-prop-2-ynyl-imidazolidin-1-ylmethyl ester (+/-)-1,3-dibenzyl-2-oxo-(3ar,8ac,8bc)-decahydro-thieno[1',2':1,2]thieno[3,4-d]imidazolium; chloride cis 1,3-Dibenzyl-4-diphenylphosphinoylmethyl-2,3,3a,4,6,6a-hexahydrofuro<3,4-d>imidazol-2-one 7-[3-(3-hydroxy-3-methyl-nonyl)-1-methyl-2,5-dioxo-imidazolidin-4-yl]-heptanoic acid ethyl ester biotin thioacetate 5-((3aS)-1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-selenolo[3,4-d]imidazol-4t-yl)-pentanoic acid 2,5,5-trioxo-(3ar,6ac)-hexahydro-5λ6-thieno[3,4-d]imidazole-1-carboxylic acid ethyl ester (1'S,3aS,4R,6aR)-4-(1'-hydroxypentyl)-1H-tetrahydrothieno<3,4-d>imidazol-2(3H)-one [4-((3aR,6S,6aS)-2-Oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-butyl]-carbamic acid 2-(2-hydroxy-ethoxy)-ethyl ester biotin thiol (3aS,4S,6aR)-4-(6-bromohexyl)-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (1'R,3aS,4R,6aR)-4-(1'-hydroxypentyl)-1H-tetrahydrothieno<3,4-d>imidazol-2(3H)-one 4t-(3-acetoxy-propyl)-1,3-dibenzyl-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one 6-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]hexanenitrile (S)-α-<<3aR-(3aα,4α,6aα)>-2-Hexahydro-2-oxo-1,3-bis(phenylmethyl)-1H-thieno<3,4-d>imidazol-4-yloxy>benzeneacetic acid 3,4-(1,3-Diallyl-2-oxoimidazolido)-thiophan cis-N-benzylperhydrothieno<3,4-d>imidazole-2-one 5,5-dioxide 3-((3aS)-1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propionic acid 6,6-dioxo-(4ar,7ac)-hexahydro-6λ6-thieno[3,4-d]pyrimidine-2,4-dione (3aα,4α,6aα)-1,3-dibenzylhexahydro-4-(pentyloxy)-1H-thieno<3,4-d>imidazol-2(3H)-one 3,4-(1',3'-Dibenzyl-2'-oxoimidazolido)-2-thiophanvaleronitril 4t-(3-acetoxy-propyl)-1,3-dibenzyl-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one 3-(1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propionaldehyde 1,3-dibenzyl-4,6,7,8,8a,8b-hexahydro-3aH-thieno[5,6]thieno[1,2-b]imidazol-5-ium-2-one,bromide (3aS)-1,3-dibenzyl-4t-(3-hydroxy-propyl)-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one (3aR)-1,3-dibenzyl-2-oxo-(3ar,8ac,8bc)-decahydro-thieno[1',2':1,2]thieno[3,4-d]imidazolium, (1R)-2-oxo-bornane-10-sulfonate 5-((3aS)-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-pent-2-enoic acid methyl ester 3,3a,4,6,7,8,8a,8b-octahydro-1H-thieno[5,6]thieno[1,2-b]imidazol-5-ium-2-one,bromide 5ξ-hydroxy-(2ar,7ac,7bc)-hexahydro-1-thia-3,4a-diaza-cyclopenta[cd]inden-4-one 5-((3aS)-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-pent-2t-enoic acid methyl ester 1,3-Dibenzyl-6-(bis-phenylsulfanyl-methyl)-tetrahydro-thieno[3,4-d]imidazol-2-one (4Z)-1-ethyl-5-imino-4-({3-methoxy-4-[(2-methylbenzyl)oxy]phenyl}methylidene)imidazolidin-2-one [3-((3aS)-1,3-dibenzyl-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propyl]-malonic acid (3aS,6aR)-1-Allyl-5,5-dioxo-hexahydro-5λ6-thieno[3,4-d]imidazol-2-one 3-(2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-propionaldehyde oxime cis-(3a,6a)-1,3-di-n-butylhexahydro-1H-thieno<3,4-d>imidazole 5,5-dioxide